News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
C. Jillian Tsai: CURB2 Ph3 RCT approved by NCI CTEP Clinical Research and will be opened through NCTN
Photo taken from C. Jillian Tsai/X
Feb 22, 2024, 11:12

C. Jillian Tsai: CURB2 Ph3 RCT approved by NCI CTEP Clinical Research and will be opened through NCTN

C. Jillian Tsai, Radiation Oncologist at Princess Margaret Cancer Centre, Toronto, Canada, shared a post on X/Twitter:

“CURB2 Ph3 RCT approved by NCI CTEP Clinical Research and will be opened through NCTN. (F/u of Ph2 CURB RCT The Lancet”

C. Jillian Tsai: CURB2 Ph3 RCT approved by NCI CTEP Clinical Research and will be opened through NCTN

Read further.

Source: C. Jillian Tsai/X

C. Jillian Tsai cancer NCI CTEP Clinical Research OncoDaily Oncology The Lancet
Special Coverage
Blog
Nov 15, 2024, 21:44
Karen Humphreys won the Advocate of the Year from the Florida Society of Clinical Oncology - UF Health Cancer Center
Blog
Nov 15, 2024, 21:37
Margaret Foti: AACR Special Conference on Liquid Biopsy
Blog
Nov 15, 2024, 21:26
Johanna Joyce: An inspiring end to our Tumor Immunology and Immunotherapy
Blog
Nov 15, 2024, 21:21
Adjuvant immunotherapy in patients with resected GEJ cancer with high risk for recurrence
Blog
Nov 15, 2024, 21:09
Miriam Knoll: An in-person lung tumor board with Nagashree Seetharamu
Insight
Nov 15, 2024, 21:05
Get Ready for ESTRO2025 Pre-Meeting Courses
Insight
Nov 15, 2024, 21:03
Explore the latest in oncology at ESMOASIA24
Insight
Nov 15, 2024, 21:02
Robin Zon: Debate day 2 of COSA
Blog
Nov 15, 2024, 20:28
Long-Term Adverse Effects and Complications After Prostate Cancer Treatment
Blog
Nov 15, 2024, 19:31
What is proton beam therapy and how does it work - Atrium Health
Blog
Nov 15, 2024, 17:47
Nico Gagelmann: Current status and Future directions for CAR-T Therapy
Insight
Nov 15, 2024, 17:45
Osteopontin as a therapeutic target in Breast Cancer recurrence